Erbitux Launch Benefits From EGFR Screening, ImClone Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Screening prospective patients for expression of epidermal growth factor receptor will positively affect Erbitux' launch, ImClone said April 27